BeiGene
ONC
#728
Rank
HK$208.50 B
Marketcap
HK$1,793
Share price
1.24%
Change (1 day)
73.48%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company